Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 12/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 9/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157644 | 1.00 | ADRB3 (0.45) | ADRB3ADRB1ADRB2SLC2A1IDO1 | |
| SCHEMBL2541814 | 1.00 | ADRB3 (0.45) | ADRB3ADRB1ADRB2SLC2A1IDO1 | |
| SCHEMBL15842311 | 0.84 | PGR (0.42) | ADRB3ADRB1ADRB2 | |
| SCHEMBL28988716 | 0.82 | GBA1 (0.40) | ADRB3ADRB1ADRB2 | |
| SCHEMBL2536163 | 0.81 | ADRB3 (0.46) | ADRB3ADRB1ADRB2 | |
| SCHEMBL768346 | 0.81 | ADRB3 (0.46) | ADRB3ADRB1ADRB2 | |
| SCHEMBL767895 | 0.81 | ADRB3 (0.46) | ADRB3ADRB1ADRB2 | |
| SCHEMBL5157831 | 0.81 | AOC3 (0.45) | ADRB3ADRB1ADRB2 | |
| SCHEMBL5157835 | 0.81 | AOC3 (0.45) | ADRB3ADRB1ADRB2 | |
| SCHEMBL2541787 | 0.81 | AOC3 (0.45) | ADRB3ADRB1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8044245-B2 | Method for the preparation of optically active 2-sulfonyloxy-1-phenylethanol derivatives | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2011-10-25 | — | — | US | disclosed |
| US-20100063317-A1 | METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-03-11 | — | — | US | disclosed |
| EP-1236714-B1 | ACETALSULFONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING STYRENE OXIDE DERIVATIVE | MITSUBISHI RAYON CO (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-6642395-B1 | Esterifying mandelic acid derivative; protecting hydroxyl group and reducing ester; sulfonating and epoxidizing | MITSUBISHI RAYON CO., LTD. (JP) | 2003-11-04 | — | — | US | disclosed |
| EP-1236714-A1 | ACETALSULFONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING STYRENE OXIDE DERIVATIVE | Mitsubishi Rayon Co., Ltd. (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063317-A1 | METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES | FOXO1, ENO1, SULT1A1 | ADRB3 653/4885ADRB1 135/4885ADRB2 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.